4.7 Review

The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

The function of LncRNA-ATB in cancer

Amir Anbiyaiee et al.

Summary: Long non-coding RNAs (lncRNAs) play crucial roles in the initiation, maintenance, and progression of cancer cells, and aberrant expression of lncRNA-ATB is associated with cancer cell growth, proliferation, metastasis, and epithelial-mesenchymal transition (EMT). LncRNA-ATB can trigger cancer pathogenesis by targeting signaling pathways and microRNAs (miRNAs).

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

Article Oncology

SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway

Pan Xu et al.

Summary: This study verified the role of SCUBE3 in hepatocellular carcinoma (HCC) progression and demonstrated that SCUBE3 promotes HCC cell proliferation by regulating CCNE1. The study also identified alterations in signaling pathways associated with SCUBE3, including the TGF beta signaling pathway and the PI3K/AKT signaling pathway.

CANCER CELL INTERNATIONAL (2022)

Review Oncology

Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives

Gunnar Folprecht et al.

Summary: Triplet chemotherapy regimens in combination with anti-EGFR agents or bevacizumab are recommended standard treatments for unresectable mCRC. While the dosing schedule of FOLFOXIRI with bevacizumab is established, the optimal dosing with anti-EGFR agents is still unknown. Clinical trials have shown improved survival and response rates with FOLFOXIRI, alone or combined with bevacizumab, for mCRC patients, and promising results with anti-EGFR agents.

CANCER TREATMENT REVIEWS (2022)

Article Biochemistry & Molecular Biology

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway

Qing Tang et al.

Summary: In this study, it was found that Solamargine (SM) can inhibit the growth of hepatocellular carcinoma (HCC) and enhance the anticancer effect of sorafenib (SF). SM exerts its effects through the HOTTIP-TUG1/miR-4726-5p/MUC1 signaling pathway. These findings provide potential therapeutic targets and strategies for HCC treatment.

MOLECULAR CARCINOGENESIS (2022)

Article Cell Biology

GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure

Hongshuang Yu et al.

Summary: Activation of GPR120 can alleviate fulminant hepatic failure by reducing liver injury and mortality. GPR120 activation decreases Th1 cell response and expands Tregs. GPR120 activation also induces a specific population of regulatory DCs in the liver. GPR120 restricts glycolysis through HIF-1α and can be attenuated by inhibiting ERK or activating AMPK.

CELL DEATH & DISEASE (2022)

Review Oncology

The roles of long non-coding RNAs in lung cancer

Zhe Cao et al.

Summary: Lung cancer is a common and deadly malignancy with increasing incidence and mortality rates. Despite the development of new therapeutic methods, the overall survival rate of lung cancer remains low. Therefore, it is crucial to focus on molecular oncology to find novel biomarkers and targets for early diagnosis, treatment, and prognosis prediction of lung cancer. Long non-coding RNAs (lncRNAs) play important roles in lung cancer and have translational potential in clinical settings.

JOURNAL OF CANCER (2022)

Article Biotechnology & Applied Microbiology

Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy

Cuifeng Xia et al.

Summary: This study reveals that long non-coding RNA TUG1 enhances the resistance of colorectal cancer cells to cisplatin through the regulation of autophagy and the activation of the miR-195-5p/HDGF/DDX5/β-catenin axis.

BIOENGINEERED (2022)

Article Biology

Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum

Alessandro Ottaiano et al.

Summary: This review provides a comprehensive and updated view on the clinical and biological characteristics of rare colorectal tumors.

BIOLOGY-BASEL (2022)

Article Biotechnology & Applied Microbiology

P53 and taurine upregulated gene 1 promotes the repair of the DeoxyriboNucleic Acid damage induced by bupivacaine in murine primary sensory neurons

Luying Lai et al.

Summary: This research aimed to explore the biological role of p53 protein and long non-coding RNA (lncRNA) TUG1 in bupivacaine-induced neurotoxicity. The results showed that p53 and TUG1 promote the repair of DNA damage induced by bupivacaine in murine dorsal root ganglion cells.

BIOENGINEERED (2022)

Review Cell Biology

An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs

Debora Bencivenga et al.

Summary: It has been established that a significant portion of the human genome is transcribed, but only a small percentage of the transcripts are translated into proteins. Most of the transcripts belong to different RNA families with various functions, including the long non-coding RNA family. Long non-coding RNAs play important roles in gene regulation, DNA modification, cellular organization, and disease development. This review focuses on the role of long non-coding RNAs in regulating cyclin-dependent kinase inhibitors' levels and activities, which are crucial for cell division control. Despite existing evidence, the importance of long non-coding RNAs in CDKI modulation and cell proliferation control is still underestimated.
Review Oncology

Emerging roles for lncRNA-NEAT1 in colorectal cancer

Shirin Azizidoost et al.

Summary: Colorectal cancer is the third leading cause of cancer death in the world. Recent studies have shown that long non-coding RNAs play important roles in colorectal cancer cells, and NEAT1 is a key factor involved in the development and progression of colorectal cancer.

CANCER CELL INTERNATIONAL (2022)

Review Medicine, Research & Experimental

LncRNAs and CircRNAs in cancer

Xin Yin et al.

Summary: It is well known that noncoding RNAs play important regulatory roles in tumors. Among them, long noncoding RNAs and circular RNAs are particularly significant and have huge potential in cancer therapy. This review focuses on the important roles of lncRNAs and circRNAs in neuroblastoma and provides rationale and relevant references for novel biomarkers in neuroblastoma diagnosis, prognosis, and treatment.

MEDCOMM (2022)

Article Biochemistry & Molecular Biology

The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway

Xiaoqiang Wang et al.

Summary: Colorectal cancer is the third most common malignant tumor, and the long non-coding RNA TUG1 plays a role in its progression by modulating the TUG1-miR-145-5p-TRPC6 axis. Targeting the TUG1-miR-145-5p-TRPC6 signaling pathway could potentially be a novel approach for the diagnosis and treatment of CRC.

BIOCHEMISTRY AND CELL BIOLOGY (2021)

Article Oncology

Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway

Miaomiao Gong et al.

Summary: This study reveals that SRC-1 promotes the stemness of GBM by activating the XIST/miR-152/KLF4 pathway, providing novel markers for diagnosis and therapy of GBM.

CANCER SCIENCE (2021)

Article Oncology

SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer

Sisi Wei et al.

Summary: The downregulation of SNHGS is associated with cancer progression, clinical outcomes, and survival rates of ESCC patients. Overexpression of SNHGS significantly inhibits the proliferation, migration, and invasion of ESCC cells. SNHGS reverses the epithelial-mesenchymal transition by interacting with MTA2.

CARCINOGENESIS (2021)

Article Oncology

Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications

Yufei Yang et al.

Summary: Colorectal cancer is a common malignancy with challenges in diagnosis and treatment, and recent research suggests that long non-coding RNAs play important roles in the progression of the disease.

CANCER LETTERS (2021)

Article Cell & Tissue Engineering

lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability

Junfeng Sun et al.

Summary: The study identified that the long noncoding RNA TUG1 enhances GATA6 protein stability, promoting the characteristics and chemoresistance of colorectal cancer stem cells.

STEM CELLS INTERNATIONAL (2021)

Article Biotechnology & Applied Microbiology

Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability

Shaomin Zhi et al.

Summary: IGF2BP2 plays a crucial role in wound healing by regulating proliferation, migration, and angiogenesis of keratinocytes. Knockdown of IGF2BP2 inhibits these processes in keratinocytes by decreasing the stability of HPSE.

BIOENGINEERED (2021)

Article Pathology

Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway

Quanlin Liu et al.

Summary: This study demonstrates that TUG1 is upregulated in CRC and promotes the progression of CRC by inhibiting the Wnt/β-catenin pathway through the miR-542-3p/TRIB2 axis.

DIAGNOSTIC PATHOLOGY (2021)

Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biochemistry & Molecular Biology

LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis

Zhenkun Yan et al.

BIOSCIENCE REPORTS (2020)

Review Oncology

The relevance of long noncoding RNAs in colorectal cancer biology and clinical settings

Atefeh Talebi et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Comprehensive review of targeted therapy for colorectal cancer

Yuan-Hong Xie et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Genetics & Heredity

Non-coding RNAs in retinal development and function

Marianthi Karali et al.

HUMAN GENETICS (2019)

Review Biochemistry & Molecular Biology

Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment

Yoshiro Itatani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Epigenetic heterogeneity in cancer

Mingzhou Guo et al.

BIOMARKER RESEARCH (2019)

Article Medicine, Research & Experimental

LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis

Chuhai Xie et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biochemistry & Molecular Biology

TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a

Bin Yang et al.

BIOSCIENCE REPORTS (2018)

Review Oncology

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer

Xinwei Huang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Article Biotechnology & Applied Microbiology

Lysine-specific demethylase 2A expression is associated with cell growth and cyclin D1 expression in colorectal adenocarcinoma

Lin-Lin Cao et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)

Review Chemistry, Medicinal

Pseudokinases: update on their functions and evaluation as new drug targets

Dominic P. Byrne et al.

FUTURE MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

Ines Marmol et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Biochemistry & Molecular Biology

TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis

Changfeng Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Review Oncology

Specificity protein 1: Its role in colorectal cancer progression and metastasis

Richa Bajpai et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Review Cell Biology

TUG1: a pivotal oncogenic long non-coding RNA of human cancers

Zheng Li et al.

CELL PROLIFERATION (2016)

Article Medicine, Research & Experimental

Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression

Hui-yuan Zhai et al.

MEDICAL SCIENCE MONITOR (2016)

Review Genetics & Heredity

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer

Ester Saus et al.

FRONTIERS IN GENETICS (2016)

Review Medical Laboratory Technology

The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring

Tanja Kunej et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)

Article Biochemistry & Molecular Biology

A Novel Histone Deacetylase Complex in the Control of Transcription and Genome Stability

Nicola Zilio et al.

MOLECULAR AND CELLULAR BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Article Medicine, General & Internal

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Medicine, General & Internal

Drug therapy - Systemic therapy for colorectal cancer

JA Meyerhardt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)